BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10873678)

  • 1. Polymorphisms in FcepsilonRI beta chain do not affect IgE-mediated mast cell activation.
    Furumoto Y; Hiraoka S; Kawamoto K; Masaki S; Kitamura T; Okumura K; Ra C
    Biochem Biophys Res Commun; 2000 Jul; 273(2):765-71. PubMed ID: 10873678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.
    Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C
    Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the FcepsilonRI beta-chain in allergic diseases.
    Kraft S; Rana S; Jouvin MH; Kinet JP
    Int Arch Allergy Immunol; 2004 Sep; 135(1):62-72. PubMed ID: 15316148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3Kgamma differentially regulates FcepsilonRI-mediated degranulation and migration of mast cells by and toward antigen.
    Endo D; Gon Y; Nunomura S; Yamashita K; Hashimoto S; Ra C
    Int Arch Allergy Immunol; 2009; 149 Suppl 1():66-72. PubMed ID: 19494508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcepsilonRI beta-chain ITAM amplifies PI3K-signaling to ensure synergistic degranulation response via FcepsilonRI and adenosine receptors.
    Nunomura S; Gon Y; Yoshimaru T; Kashiwakura J; Kawakami T; Ra C
    Eur J Immunol; 2010 Apr; 40(4):1205-17. PubMed ID: 20101614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA-1 is required for expression of Fc{epsilon}RI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow.
    Nishiyama C; Ito T; Nishiyama M; Masaki S; Maeda K; Nakano N; Ng W; Fukuyama K; Yamamoto M; Okumura K; Ogawa H
    Int Immunol; 2005 Jul; 17(7):847-56. PubMed ID: 15967781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.
    Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
    Han EH; Park JH; Kim JY; Jeong HG
    Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response.
    Liu Y; Zhu M; Nishida K; Hirano T; Zhang W
    J Exp Med; 2007 Jan; 204(1):93-103. PubMed ID: 17190838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells.
    Péterfy H; Tóth G; Pecht I; Erdei A
    Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super-oxidized solution inhibits IgE-antigen-induced degranulation and cytokine release in mast cells.
    Medina-Tamayo J; Sánchez-Miranda E; Balleza-Tapia H; Ambriz X; Cid ME; González-Espinosa D; Gutiérrez AA; González-Espinosa C
    Int Immunopharmacol; 2007 Aug; 7(8):1013-24. PubMed ID: 17570318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE-mediated mast cell degranulation and recovery monitored by time-lapse photography.
    Xiang Z; Block M; Löfman C; Nilsson G
    J Allergy Clin Immunol; 2001 Jul; 108(1):116-21. PubMed ID: 11447391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcεRI-induced mast cell cytokine production critically involves an aspartic acid residue (D234) in the C-terminal intracellular domain of the FcεRIβ chain.
    Terada T; Nunomura S; Shimokawa T; Murayama K; Era S; Kondo N; Ra C
    Biochem Biophys Res Commun; 2011 Jul; 410(4):744-8. PubMed ID: 21683687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an in vitro mast cell degranulation test in the context of food allergy to wheat.
    Bodinier M; Brossard C; Triballeau S; Morisset M; Guérin-Marchand C; Pineau F; de Coppet P; Moneret-Vautrin DA; Blank U; Denery-Papini S
    Int Arch Allergy Immunol; 2008; 146(4):307-20. PubMed ID: 18367844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing Fcepsilon-Bak chimeric protein for studying IgE-FcepsilonRI interactions.
    Belostotsky R; Lorberboum-Galski H
    Clin Immunol; 2004 Jan; 110(1):89-99. PubMed ID: 14962800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3.
    Okoshi Y; Tahara-Hanaoka S; Nakahashi C; Honda S; Miyamoto A; Kojima H; Nagasawa T; Shibuya K; Shibuya A
    Int Immunol; 2005 Jan; 17(1):65-72. PubMed ID: 15569773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid targets CD44 and inhibits FcepsilonRI signaling involving PKCdelta, Rac1, ROS, and MAPK to exert anti-allergic effect.
    Kim Y; Lee YS; Hahn JH; Choe J; Kwon HJ; Ro JY; Jeoung D
    Mol Immunol; 2008 May; 45(9):2537-47. PubMed ID: 18289679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RabGEF1, a negative regulator of Ras signalling, mast cell activation and skin inflammation.
    Tam SY; Kalesnikoff J; Nakae S; Tsai M; Galli SJ
    Novartis Found Symp; 2005; 271():115-24; discussion 124-30, 145-51. PubMed ID: 16605131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective impairment of FcepsilonRI-mediated allergic reaction in Gads-deficient mice.
    Yamasaki S; Takase-Utsugi M; Ishikawa E; Sakuma M; Nishida K; Saito T; Kanagawa O
    Int Immunol; 2008 Oct; 20(10):1289-97. PubMed ID: 18664516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procyanidin C1 from apple extracts inhibits Fc epsilon RI-mediated mast cell activation.
    Nakano N; Nishiyama C; Tokura T; Nagasako-Akazome Y; Ohtake Y; Okumura K; Ogawa H
    Int Arch Allergy Immunol; 2008; 147(3):213-21. PubMed ID: 18594151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.